BioCentriq Name of First Cell and Gene Therapy Development and Manufacturing Center Located on a University Campus in the U.S.
NJII announces that qualification and validation of its clinical manufacturing facility for cell and gene therapies is underway, and the name of the center will be BioCentriq. May 4, 2020: … Continue reading
April 20, 2020, Newark, NJ – New Jersey Innovation Institute’s (NJII) announced today that Jennifer D’Angelo will join NJII as a Vice President and General Manager, effective May 4th. She … Continue reading
The New Jersey Innovation Institute (NJII) has appointed Dr. Deirdre Letson-Christofalo as vice president of its Human Capital Division and Dan Kaminski as vice president and general manager of Data … Continue reading
April 6, 2020, Newark, NJ – Tomas Gregorio, the senior vice president and general manager of the New Jersey Innovation Institute’s (NJII) Healthcare Division announced today that he has accepted … Continue reading
NJBIZ has named New Jersey Innovation Institute (NJII) President and Chief Innovation Officer Donald Sebastian and NJIT President Joel Bloom to its Power 100 list of leaders who have done the … Continue reading
It is evident that the cell and gene therapy sectors are growing faster than the field of available talent, pressuring start-ups and established players alike. That was the key driver … Continue reading
NEWARK, NJ, Dec 17, 2019 – New Jersey Innovation Institute (NJII) President, Donald H. Sebastian and NJII Board Members, Dean Paranicas, Michele Siekerka and Debbie Hart have been named to the … Continue reading